Initiation de nouvelles études cliniques (septembre – octobre 2026)

Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations (sTTRing)

• 👤 Sponsor : AstraZeneca

• 📅 Study start : 01/09/2026

• 📒 Study Type : Observational, Retrospective

• 🆔 NCT07654855

• 🔗 https://clinicaltrials.gov/study/NCT07654855

Detection of Cardiac Amyloidosis Using Right Ventricular Sensing Amplitude in Patients With Left Ventricular Hypertrophy (DETECT-AMY)

• 👤 Sponsor : APHP - Contact : Samia BALOUL

• 📅 Study start (estimated) : 01/09/2026

• 📒 Study Type :Interventional (Diagnostic Test: Cardiac amyloidosis screening during CIED implantation)

• 🆔NCT07734285

• 🔗 https://clinicaltrials.gov/study/NCT07734285

Retrospective Identification of Scintigraphic Cardiac Amyloidosis (RISCA) (RISCA)

• 👤 Sponsor : University Hospital, Lille - Contact : Marc-Antoine DELBARRE

• 📅 Study start (estimated) : 01/09/2026

• 📒 Study Type : Observational, Retrospective

• 🆔 NCT06921408

• 🔗 https://clinicaltrials.gov/study/NCT06921408

————————————————————————————————————————————

Study of Acoramidis in Patients With Transthyretin Amyloid Cardiomyopathy (MOSAIC-TTR)

• 👤 Sponsor : Bayer

• 📅 Study start : 07/09/2026 - Recruiting

• 📒 Study Type : Observational, Prospective (Phase 4)

• 🆔 NCT07791160

• 🔗 https://clinicaltrials.gov/study/NCT07791160

Etude soutenue par le réseau F-CRIN GRACE (voir la page projet)

————————————————————————————————————————————-

Exploratory study evaluating the relevance of [68Ga] Ga-FAPI-46 for staging and identifying progressing patients with transthyretin cardiac amyloidosis (FAPICAM)

• 👤 Sponsor : Centre Hospitalier Universitaire De Nantes - Contact : Thomas EUGENE

• 📅 Study start : 09/09/2026 - Recruiting

• 📒 Study Type : Therapeutic exploratory, Interventional (Phase II)

• 🆔 EUCT n° 2025-523616-36-00, NCT07549841

• 🔗 https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2025-523616-36-00 and https://clinicaltrials.gov/study/NCT07549841

  
  

Individualized Exercise Training in Cardiac Amyloidosis (GET-FIT ATTR)

• 👤 Sponsor : Oregon Health and Science University

• 📅 Study start : 09/09/2026 - Recruiting

• 📒 Study Type : Therapeutic exploratory, Interventional (Phase II)

• 🆔 NCT07835867

• 🔗https://clinicaltrials.gov/study/NCT07835867

Prevalence of Cardiac Thrombi in Cardiac Amyloidosis (CATICA)

• 👤 Sponsor : Centre Hospitalier Universitaire Dijon : - Contact : Benjamin Ferrand

• 📅 Study start : 07/09/2026 - Recruiting

• 📒 Study Type : Interventional

• 🆔NCT07648303

• 🔗 https://clinicaltrials.gov/study/NCT07648303

Impact of a Cardiac Rehabilitation Program on Patients With Cardiac Amyloidosis (RECARDA)

• 👤 Sponsor : University Hospital, Montpellier : - Contact : Johanna KRIEF & Susan Martinez

• 📅 Study start : 23/09/2026 - Recruiting

• 📒 Study Type : Interventional (Cardiac Rehabilitation Program)

• 🆔NCT07494942

• 🔗 https://clinicaltrials.gov/study/NCT07494942

  
  

An Open-Label Study to Investigate the Long-Term Effects of Acoramidis on Cardiac Function, Structure and Cardiac Amyloid Burden in Participants with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

• 👤 Sponsor : Eidos Therapeutics Inc

• 📅 Study start : 24/09/2026 - Recruiting

• 📒 Study Type : Therapeutic use (Phase IV)

• 🆔 EUCT n° 2026-526068-19-00

• 🔗 https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2026-526068-19-00

Southeastern ATTR Amyloidosis Consortium: SEATTRAC Family Registry

• 👤 Sponsor : Virginia Commonwealth University

• 📅 Study start ( Estimated) : 09/2026

• 📒 Study Type : Observational [Patient Registry]

• 🆔 NCT05974644

• 🔗 https://clinicaltrials.gov/study/NCT05974644

PET Imaging Study Using Evuzamitide to Detect Cardiac Amyloidosis in Patients With Inconclusive Nuclear Scans and Elevated TAD1 Levels (TRACE)

• 👤 Sponsor : University of Texas - Contact : Lorena Saelices,

• 📅 Study start (estimated) : 01/10/2026

• 📒 Study Type : Observational, prospective

• 🔗 https://clinicaltrials.gov/study/NCT07538518

Right Ventricular Septal Biopsy to Detect Cardiac Amyloidosis (RV-CAM)

• 👤 Sponsor : Geisinger Clinic - Contact : Grace Hughes

• 📅 Study start (estimated) : .../10/2026

• 📒 Study Type : Observational, prospective

• 🔗 https://clinicaltrials.gov/study/NCT07784712

Effect of Trimetazidine on Coronary Flow in Transthyretin Cardiac Amyloidosis (TACT-TTR)

• 👤 Sponsor : Fábio Fernandes

• 📅 Study start (estimated) : .../10/2026

• 📒 Study Type : Observational, prospective

• 🔗 https://clinicaltrials.gov/study/NCT07784712

Single-arm, Multi-center Study Evaluating the Acceptance and Feasibility of a Digital Remote Monitoring Tool Configured for Patients With ATTR-CM: ACO-Monitor (ACO-MONITOR)

• 👤 Sponsor : Bayer

• 📅 Study start (estimated) : 30/10/2026

• 📒 Study Type : Observational, Prospective

• 🆔 NCT07557147

• 🔗 https://clinicaltrials.gov/study/NCT07557147

Publication de résultats d'études cliniques (septembre – octobre 2026)

Open-Label Study of AG10 in Patients With Cardiomyopathy

• 👤 Sponsor : Eidos Therapeutics, a BridgeBio company

• 📅Results First Submitted : 18/09/2026

• 📒 Study Type : Interventional

• 🔗https://clinicaltrials.gov/study/NCT03536767